Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Profit from core business operations before interest and taxes
3Y CAGR
+7.7%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $11.49M | -28.9% |
| 2024 | $16.16M | +124.0% |
| 2023 | $-67.23M | -830.5% |
| 2022 | $9.20M | +111.0% |
| 2021 | $-83.73M | -45.9% |
| 2020 | $-57.37M | -0.2% |
| 2019 | $-57.28M | -69.3% |
| 2018 | $-33.82M | -55.0% |
| 2017 | $-21.82M | -6.9% |
| 2016 | $-20.42M | - |